Showing 1 - 10 of 5,879
Persistent link: https://www.econbiz.de/10011337714
-adjusted mortality rates of residents of Germany, using longitudinal, annual, state-level data during the period 2000-2007. The estimates …I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I …-adjusted cancer mortality rates of residents of France, using longitudinal, annual, cancer-site-level data during the period 2002 …
Persistent link: https://www.econbiz.de/10003977959
Persistent link: https://www.econbiz.de/10003729378
-adjusted mortality rates of residents of Germany, using longitudinal, annual, state-level data during the period 2000-2007. The estimates …I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I …-adjusted cancer mortality rates of residents of France, using longitudinal, annual, cancer-site-level data during the period 2002 …
Persistent link: https://www.econbiz.de/10013069689
Users can develop innovations which will benefit other people and contribute to firm’s innovation capability. However, user innovation often fails to diffuse. In this study, we take the perspective of vocational and retirement studies to analyze whether the older age (60+ years old) of the...
Persistent link: https://www.econbiz.de/10014077523
Persistent link: https://www.econbiz.de/10012200239
Persistent link: https://www.econbiz.de/10011964261
I analyze the effects of four types of medical innovation and cancer incidence on US cancer mortality rates during the … pre‐dated factors that drove both innovation and mortality and that there would have been parallel trends in mortality in …-adjusted cancer mortality rate during 2000–2009. Drug innovation and imaging innovation are estimated to have reduced the cancer …
Persistent link: https://www.econbiz.de/10010466909
Persistent link: https://www.econbiz.de/10011701670
Persistent link: https://www.econbiz.de/10014250114